口腔白斑非药物治疗的研究进展

doi:10.13701/j.cnki.kqyxyj.2023.02.001

口腔医学研究 ›› 2023, Vol. 39 ›› Issue (2): 97-100.DOI: 10.13701/j.cnki.kqyxyj.2023.02.001

• 特约述评 • 下一篇

口腔白斑非药物治疗的研究进展

唐瞻贵^*, 郭俊涛

湖南中南大学湘雅口腔医院,中南大学湘雅口腔医学院,湖南省口腔重大疾病与口腔健康临床医学研究中心湖南长沙 410008

收稿日期:2022-05-11 出版日期:2023-02-28 发布日期:2023-02-20
通讯作者: * 唐瞻贵,E-mail:tangzhangui@aliyun.com
作者简介:唐瞻贵,男,中国共产党党员,医学博士,博士后,一级主任医师,二级教授,湘雅名医,博士生导师,享受国务院政府特殊津贴。现任中南大学湘雅口腔医院院长,口腔医学院院长,口腔医学研究所所长。中国整形美容协会口腔整形美容分会副会长,中国抗癌协会口腔颌面肿瘤整合医学专业委员会副主任委员,中国牙病防治基金会理事会理事,湖南省口腔健康促进会会长,湖南省口腔医学会副会长。《口腔医学研究》副主编,《中华口腔医学杂志》、《中国口腔颌面外科杂志》等10余部杂志编委。主持国家自然科学基金等国家级课题6项,国家博士点基金、省科技厅重点项目等省部级项目20余项,获湖南省科技进步三等奖2项,湖南医学科技二等奖2项,教育部成果1项。主编、参编著作10余部,主持《口腔疣状癌临床诊治全国专家共识》及《口腔医学中恶性高热临床诊治中国专家共识》的讨论和撰写。
基金资助:
国家自然科学基金面上项目(编号:82170972)

Research Progress in Non-pharmacological Treatment of Oral Leukoplakia

TANG Zhangui^*, GUO Juntao

Hunan Clinical Research Center of Oral Major Diseases and Oral Health, Xiangya School of Stomatology, Xiangya Stomatological Hospital, Central South University, Changsha 410008, China

Received:2022-05-11 Online:2023-02-28 Published:2023-02-20

摘要/Abstract

摘要： 口腔白斑是临床上最常见的口腔潜在恶性疾病之一,其发病率高、癌变可能性大,临床上将其分为均质型和非均质型,后者更易发展为口腔癌。口腔白斑的治疗方法分为药物治疗和非药物治疗,相比较药物治疗,非药物治疗适应证广、见效较快,已成为临床上治疗口腔白斑的主要选择。本文就目前国内外临床口腔白斑治疗常用的非药物疗法如激光、光动力疗法及传统外科手术做一综述,总结各方法的作用特点、治疗效果等,以期为临床治疗口腔白斑提供一定的参考。

关键词: 口腔白斑, 潜在恶性疾病, 非药物治疗

Abstract: Oral leukoplakia is one of the most common potential oral malignant diseases with high incidence and high possibility of cancerization. It can be clinically divided into homogeneous type and heterogeneous type, and the latter is more likely to develop into oral cancer. Oral leukoplakia treatment is divided into drug treatment and non-pharmacological treatment, compared with the former, the latter has a wide range of indications and quick effect. It has become the main choice for the treatment of oral leukoplakia in clinic. This paper summarizes the common non-pharmacological treatment methods for oral leukoplakia domestic and overseas such as laser, photodynamic therapy and traditional surgery, which includes their action characteristics and therapeutic effects. We hopely provide some references for the clinical treatments of oral leukoplakia.

Key words: oral leukoplakia, potentially malignant disease, non-pharmacological treatment

唐瞻贵, 郭俊涛. 口腔白斑非药物治疗的研究进展[J]. 口腔医学研究, 2023, 39(2): 97-100.

TANG Zhangui, GUO Juntao. Research Progress in Non-pharmacological Treatment of Oral Leukoplakia[J]. Journal of Oral Science Research, 2023, 39(2): 97-100.

参考文献

[1] Chen Q, Dan H, Pan W, et al. Management of oral leukoplakia: a position paper of the Society of Oral Medicine, Chinese Stomatological Association [J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2021, 132(1):32-43.
[2] Villa A, Woo SB. Leukoplakia-A diagnostic and management algorithm [J]. J Oral Maxillofac Surg, 2017, 75(4):723-734.
[3] Lodi G, Franchini R, Warnakulasuriya S, et al. Interventions for treating oral leukoplakia to prevent oral cancer [J]. Cochrane Database Syst Rev, 2016, 7(7):CD001829.
[4] Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies [J]. J Oral Pathol Med, 2016, 45(3):155-166.
[5] van der Hem PS, Nauta JM, van der Wal JE, et al. The results of CO₂ laser surgery in patients with oral leukoplakia: a 25 year follow up [J]. Oral Oncol, 2005, 41(1):31-37.
[6] Nammour S, Zeinoun T, Namour A, et al. Evaluation of different laser-supported surgical protocols for the treatment of oral leukoplakia: A long-term follow-up [J]. Photomed Laser Surg, 2017, 35(11):629-638.
[7] Ben-Bassat M, Kaplan I, Shindel Y, et al. The CO₂ laser in surgery of the tongue [J]. Br J Plast Surg, 1978, 31(2):155-156.
[8] Yang SW, Lee YS, Wu PW, et al. A retrospective cohort study of oral leukoplakia in female patients-analysis of risk factors related to treatment outcomes [J]. Int J Environ Res Public Health, 2021, 18(16):8319.
[9] Romeo U, Mohsen M, Palaia G, et al. CO₂ laser ablation of oral leukoplakia: with or without extension of margins? [J]. Clin Ter, 2020, 171(3):e209-e215.
[10] Dong Y, Chen Y, Tao Y, et al. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis [J]. Lasers Med Sci, 2019, 34(1):209-221.
[11] Tewari M, Rai P, Singh GB, et al. Long-term follow-up results of Nd: YAG laser treatment of premalignant and malignant (Stage I) squamous cell carcinoma of the oral cavity [J]. J Surg Oncol, 2007, 95(4):281-285.
[12] Vivek V, Jayasree RS, Balan A, et al. Three-year follow-up of oral leukoplakia after neodymium:yttrium aluminum garnet (Nd:YAG) laser surgery [J]. Lasers Med Sci, 2008, 23(4):375-379.
[13] Das S, Mohammad S, Singh V, et al. Neodymium:Yttrium aluminum garnet laser in the management of oral leukoplakia: A case series [J]. Contemp Clin Dent, 2015, 6(Suppl 1):S32-S35.
[14] Del Corso G, Gissi DB, Tarsitano A, et al. Laser evaporation versus laser excision of oral leukoplakia: A retrospective study with long-term follow-up [J]. J Craniomaxillofac Surg, 2015, 43(6):763-768.
[15] Jurczyszyn K, Kozakiewicz M. Application of texture and fractal dimension analysis to estimate effectiveness of oral leukoplakia treatment using an Er:YAG laser-A prospective study [J]. Materials (Basel), 2020, 13(16):3614.
[16] Gabri D, Brailo V, Ivek A, et al. Evaluation of innovative digitally controlled ER:YAG laser in surgical treatment of oral leukoplakia -A preliminary study [J]. Acta Clin Croat, 2019, 58(4):615-620.
[17] Matuli N, Bago I, Suši M, et al. Comparison of Er:YAG and Er,Cr:YSGG laser in the treatment of oral leukoplakia lesions refractory to the local retinoid therapy [J]. Photobiomodul Photomed Laser Surg, 2019, 37(6):362-368.
[18] Arduino PG, Cafaro A, Cabras M, et al. Treatment outcome of oral leukoplakia with Er:YAG laser: A 5-year follow-up prospective comparative study [J]. Photomed Laser Surg, 2018, 36(12):631-633.
[19] Monteiro L, Barbieri C, Warnakulasuriya S, et al. Type of surgical treatment and recurrence of oral leukoplakia: A retrospective clinical study [J]. Med Oral Patol Oral Cir Bucal, 2017, 22(5):e520-e526.
[20] Kharadi UA, Onkar S, Birangane R, et al. Treatment of oral leukoplakia with diode laser: a pilot study on Indian subjects [J]. Asian Pac J Cancer Prev, 2015, 16(18):8383-8386.
[21] 马芮,刘耀然,赵继志.激光治疗口腔黏膜白斑研究进展[J].中国实用口腔科杂志,2018,11(09):564-568.
[22] Lauritano D, Lucchese A, Gabrione F, et al. The Effectiveness of laser-assisted surgical excision of leukoplakias and hyperkeratosis of oral mucosa: A case series in a group of patients [J]. Int J Environ Res Public Health, 2019, 16(2):210.
[23] Vlk M, Smucler R. The efficacy of diode laser removal of leukoplakias on the tongue and in lower buccal cavity compared to other buccal cavity locations: A two-year study [J]. Cen Eur J Med, 2012, 8(2):192-203.
[24] 史恩宇,李志远,潘伟,等.光动力治疗口腔黏膜白斑的研究进展[J].中国激光医学杂志,2020,29(6):355-361.
[25] 赵进进,蔡扬.光动力疗法治疗口腔白斑疗效影响因素研究进展[J].口腔医学研究,2022,38(4):304-307.
[26] Li Y, Wang B, Zheng S, et al. Photodynamic therapy in the treatment of oral leukoplakia: A systematic review [J]. Photodiagnosis Photodyn Ther, 2019, 25:17-22.
[27] Chen Q, Dan H, Tang F, et al. Photodynamic therapy guidelines for the management of oral leucoplakia [J]. Int J Oral Sci, 2019, 11(2):14.
[28] 但红霞,肖妍荻,曾昕,等.口腔白斑病ALA光动力治疗文献回顾[J].中国激光医学杂志,2021,30(1):21-22.
[29] Han Y, Xu S, Jin J, et al. Primary clinical evaluation of photodynamic therapy with oral leukoplakia in Chinese patients [J]. Front Physiol, 2019, 9:1911.
[30] Yao Y, Shi L, Wang Y, et al. Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: A randomized, controlled pilot study [J]. Photodiagnosis Photodyn Ther, 2021, 36:102523.
[31] Binnal A, Tadakamadla J, Rajesh G, et al. Photodynamic therapy for oral potentially malignant disorders: A systematic review and meta-analysis [J]. Photodiagnosis Photodyn Ther, 2022, 37:102713.
[32] Kawczyk-Krupka A, Wakowska J, Raczkowska-Siostrzonek A, et al. Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia [J]. Photodiagnosis Photodyn Ther, 2012, 9(2):148-155.
[33] Kuribayashi Y, Tsushima F, Sato M, et al. Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy [J]. J Oral Pathol Med, 2012, 41(9):682-688.
[34] Holmstrup P, Dabelsteen E. Oral leukoplakia-to treat or not to treat [J]. Oral Dis, 2016, 22(6):494-497.
[35] 贾婷婷,杨婷,杜岩,等.口腔白斑的手术治疗选择[J].中华老年口腔医学杂志,2018,16(5):312-315.
[36] Mehanna HM, Rattay T, Smith J, et al. Treatment and follow-up of oral dysplasia-a systematic review and meta-analysis [J]. Head Neck, 2009, 31(12):1600-1609.
[37] Holmstrup P, Vedtofte P, Reibel J, et al. Long-term treatment outcome of oral premalignant lesions [J]. Oral Oncol, 2006, 42(5):461-474.
[38] Sundberg J, Korytowska M, Holmberg E, et al. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study [J]. PLoS One, 2019, 14(12):e0225682.

口腔白斑非药物治疗的研究进展

Research Progress in Non-pharmacological Treatment of Oral Leukoplakia

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics